BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8547322)

  • 21. The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues.
    Turley H; Comley M; Houlbrook S; Nozaki N; Kikuchi A; Hickson ID; Gatter K; Harris AL
    Br J Cancer; 1997; 75(9):1340-6. PubMed ID: 9155056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of DNA topoisomerases in chronic proliferative kidney disease.
    Ivanova LV; Rudolph P; Kellner U; Jürgensen A; Tareeva IE; Alm P; Proppe D
    Kidney Int; 2000 Oct; 58(4):1603-12. PubMed ID: 11012894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S; Smit EF; Meersma GJ; van den Berg A; Timmer-Bosscha H; Kok K; Postmus PE; Mulder NH; de Vries EG; Buys CH
    Lab Invest; 1994 Jul; 71(1):61-6. PubMed ID: 8041119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.
    Rijavec M; Silar M; Triller N; Kern I; Cegovnik U; Košnik M; Korošec P
    Pathol Oncol Res; 2011 Sep; 17(3):691-6. PubMed ID: 21455636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.
    Coutts J; Plumb JA; Brown R; Keith WN
    Br J Cancer; 1993 Oct; 68(4):793-800. PubMed ID: 8398710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
    Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
    Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of the topoisomerase II alpha and beta genes in human breast cancers.
    Sandri MI; Hochhauser D; Ayton P; Camplejohn RC; Whitehouse R; Turley H; Gatter K; Hickson ID; Harris AL
    Br J Cancer; 1996 Jun; 73(12):1518-24. PubMed ID: 8664122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development.
    Capranico G; Tinelli S; Austin CA; Fisher ML; Zunino F
    Biochim Biophys Acta; 1992 Aug; 1132(1):43-8. PubMed ID: 1380833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistance protein and topoisomerase 2 alpha expression in non-small cell lung cancer are related with brain metastasis postoperatively.
    Huang H; Liu J; Meng Q; Niu G
    Int J Clin Exp Pathol; 2015; 8(9):11537-42. PubMed ID: 26617887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
    Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
    Gupta D; Shidham V; Holden J; Layfield L
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of DNA topoisomerase I, DNA topoisomerase II-alpha, and p53 in metastatic malignant melanoma.
    Lynch BJ; Komaromy-Hiller G; Bronstein IB; Holden JA
    Hum Pathol; 1998 Nov; 29(11):1240-5. PubMed ID: 9824101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
    Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
    Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
    Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.
    Kreisholt J; Sorensen M; Jensen PB; Nielsen BS; Andersen CB; Sehested M
    Br J Cancer; 1998 May; 77(9):1469-73. PubMed ID: 9652763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
    Ceppi P; Longo M; Volante M; Novello S; Cappia S; Bacillo E; Selvaggi G; Saviozzi S; Calogero R; Papotti M; Scagliotti GV
    J Thorac Oncol; 2008 Jun; 3(6):583-9. PubMed ID: 18520795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation.
    Zandvliet DW; Hanby AM; Austin CA; Marsh KL; Clark IB; Wright NA; Poulsom R
    Biochim Biophys Acta; 1996 Jun; 1307(2):239-47. PubMed ID: 8679710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.